Hospital Outcomes for Neonates Exposed to Methamphetamine Prenatally

  • Bernadette Baker
  • Gracie Evans Texas Tech University Health Sciences Center
  • Nimra Pasha
  • Jenda Arawiran
Keywords: Neonatal outcome, methamphetamine, prenatal care


Objective: Methamphetamine use remains a problem, with a reported prevalence of 14 to 57 million of all 15-64-year-olds in the United States. However, there is limited knowledge about neonatal outcomes following in-utero exposure to methamphetamine. This study describes the short-term outcomes of infants born with confirmed methamphetamine exposure. Study Design: A retrospective chart review was conducted, and a total of 51 neonates were found to have positive drug screens. Result: Neonatal subjects had an average gestational age of 38 weeks and an average birth weight of 3.142 kg. Twenty-six neonates (50.98%) were admitted to the NICU with an average stay of 11.12 days. Maternal subjects were primarily Caucasian, had not obtained a high school diploma, frequently used tobacco, and had public insurance. Conclusion: Many of our findings were similar to the 2014 Infant Development, Environment, and Lifestyle Study (IDEAL). A large percentage of our patient population required NICU admission. However, the infants were of average size and gestational age.


1. Arria AM, Derauf C, Lagasse LL, et al. Methamphetamine and other substance use during pregnancy: preliminary estimates from the Infant Development, Environment, and Lifestyle (IDEAL) study. Matern. Child Health J 2006; 10(3): 293-302.
2. Shah, R, Diaz, S, Arria, A, et al. Prenatal Methamphetamine Exposure and Neonatal and Infant Neurobehavioral Outcome: Results from the IDEAL Study. Subst Abus 2014; 35(1): 68-73.
3. Haning, W, Strauss, A, Della Grotta, S, et al. Prenatal Methamphetamine Exposure and Short-Term Maternal and Infant Medical Outcomes. Amer J Perinatol 2012; 29(05): 391-400
4. LaGasse, L, Wouldes, T, Newman, E, et al. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicol Teratol 2011; 33(1): 166-75.
5. Smith LM, Lagasse LL, Derauf C, et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 2008; 30(1): 20–28.
6. Behnke, M, Smith, VC. Prenatal Substance Abuse: Short-and Long-term Effects on the Exposed Fetus. Pediatrics 2013; 131(3): 1009-1024.
7. Graves L, Green C, Robert M, Cook J. Methamphetamine use in pregnancy: A call for action. J Obstet Gynaecol Can 2020; S1701-2163(20): 30971-2.
8. Irene Guat Sim Cheah. Economic assessment of neonatal intensive care. Transl Pediatr 2019; 8(3): 246-256.
9. Wright TE, Schuetter R, Tellei J, Sauvage L. Methamphetamines and pregnancy outcomes. J Addict Med 2015; 9(2): 111-117.
How to Cite
Bernadette Baker, Gracie Evans, Nimra Pasha, & Jenda Arawiran. (2022). Hospital Outcomes for Neonates Exposed to Methamphetamine Prenatally. International Journal of Integrative Pediatrics and Environmental Medicine, 7, 13 - 16.